跳至主要内容
临床试验/NL-OMON39344
NL-OMON39344已完成不适用

Evaluating the relationship between haemodialysis and glucose control in insulin-treated diabetic patients - a pilot study - CGM in DM patients on haemodialysis

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - insulin treated diabetes (type 1 or type 2) on haemodialysis
  • - age 18 years or older
  • - male or female

排除标准

  • - secondary form of diabetes
  • - use of oral hypoglycaemic drugs
  • - use of oral/parental glucocorticoids
  • - inability to understand written and oral instructions in Dutch and to adhere to study protocol

研究者

相似试验

招募中
不适用
Evaluating glucose control before, during and after haemodialysis in patients with diabetes who are using insulin.diabetes mellitushaemodialysiscontinuous glucose monitoring
NL-OMON20090niversity Medical Center Groningen20
已完成
4 期
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal disease
ISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
已完成
不适用
Influence of hemodialysis, hemodiafiltration and peritoneal dialysis on asymmetric dimethylarginine and markers of oxidative stressEnd stage renal diseaseMetabolic and Endocrine - Diabetes
ACTRN12611000577910Research Project No. MSM 0021620819, Ministry of Health, Czech Republic.60
已完成
不适用
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)
JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40
招募中
不适用
Correlations of Hemodialysis Adequacy Using Online Clearance Monitoring (Kt/VOCM) and Single-Pool Kt/V with Daugirdas' Second Generation Formula (Kt/VDau) at Bhumirajanakarindra Kidney Institute Hospitalend&#45stage renal disease patientschronic hemodialysisKt/VOnline clearance monitoring (OCM)Daugirdas&#39s second generation formulationV watson formulationV body composition monitoring (BCM)
TCTR20191106005Bhumirajanagarindra Kidney Institute Hospital100